...
首页> 外文期刊>Computational and Structural Biotechnology Journal >Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19
【24h】

Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19

机译:抗氧化剂和偏毒素作为Coadjuvant标准治疗的措施,以改善Covid-19肺炎患者预后的措施

获取原文
           

摘要

The type 2 coronavirus causes severe acute respiratory syndrome (SARS-CoV-2) and produces pneumonia with pulmonary alveolar collapse. In some cases it also causes sepsis and septic shock. There is no specific treatment for coronavirus disease 2019 (COVID-19). Vitamin C (Vit C), Vitamin E (Vit E), N-acetylcysteine (NAC) and Melatonin (MT) increase the intracellular content of GSH, kidnap free radicals and protect DNA, proteins in the cytosol and lipids in cell membranes. Pentoxifylline (Px) has anti-inflammatory activities. Here we evaluate the effect of Vit C, Vit E, NAC, and MT plus Px in COVID-19 patients with moderate and severe pneumonia. 110 patients of either sex were included. They were divided into five groups with 22 patients each. Group 1 received Vit C? ?Px, group 2 Vit E? ?Px, group 3 NAC? ?Px, group 4 MT? ?Px, and group 5 only Px. Oxidative stress (OS) markers such as lipid peroxidation (LPO) levels, total antioxidant capacity (TAC) and nitrites (NO 2 – ) were evaluated in plasma. The antioxidant therapy improved the survival scores including the Sequential Organ Failure Assessment (SOFA), the Acute Physiology and chronic Health Evaluation II (Apache II), the Simplified Acute Physiology Score II (SAPS II), the Critical Illness Risk Score, Launched during COVID-19 crisis (COVIDGRAM) and the Glasgow Coma Scale (GCS). We found that LPO (p≤0.04) and inflammation markers such as interleukin-6 (IL-6, p≤ 0.01), C reactive protein (CRP, p ≤ 0.01) and procalcitonin (PCT, p ≤ 0.05) were elevated. TAC (p ≤ 0.03) and NO 2 – (p ≤ 0.04) found themselves diminished in diminished in COVID-19 patients upon admission to the hospital. The different antioxidants reversed this alteration at the end of the treatment. The treatment with antioxidant supplements such as Vit C, E, NAC, and MT plus Px could decelerate the aggressive and lethal development of COVID-19. Antioxidant therapy can be effective in this pandemia since it improves the survival scores including SOFA, Apache II, SAPS II, COVIDGRAM, GCS by lowering the LPO, IL-6, CRP, PCT and increasing systemic TAC and NO 2 – .
机译:2型冠状病毒导致严重的急性呼吸综合征(SARS-COV-2),并产生肺肺泡塌陷的肺炎。在某些情况下,它也会导致败血症和脓毒症休克。 2019年冠状病毒疾病(Covid-19)没有具体治疗方法。维生素C(VIT C),维生素E(VITE),N-乙酰半胱氨酸(NAC)和褪黑激素(MT)增加了GSH,绑扎自由基的细胞内含量,在细胞膜中的细胞溶胶和脂质中的蛋白质。 pentoxifylline(px)具有抗炎活动。在这里,我们评估vit C,Vit E,NAC和MT Pl PX在Covid-19中度和严重肺炎的患者中的影响。包括任何两种性别的110名。它们分为五组,每个患者22例。第1组接受了vit c? ?PX,第2组VIT E? ?PX,第3组NAC? ?PX,第4宫一组? ?PX,第5组仅限PX。在血浆中评估氧化应激(OS)诸如脂质过氧化(LPO)水平,总抗氧化能力(TAC)和亚硝酸盐(NO 2 - )的标记物。抗氧化治疗改善了包括顺序器官失效评估(沙发),急性生理学和慢性健康评估II(Apache II)的存活率,简化的急性生理学得分II(SAPS II),临界疾病风险评分,在Covid期间发布-19危机(Covidgram)和Glasgow Coma Scale(GCS)。我们发现LPO(P≤0.04)和炎症标志物,如白细胞介素-6(IL-6,P≤0.01),C反应蛋白(CRP,P≤0.01)和ProCalcitonin(PCT,P≤0.05)升高。 TAC(p≤0.03)和2 - (p≤0.04)发现本身在Covid-19患者入院时减少了在医院的患者中减少。不同的抗氧化剂在治疗结束时逆转了这种改变。用抗氧化剂补充剂如VIT C,E,NAC和MT Plus PX的处理可以减少Covid-19的侵袭性和致命的发育。抗氧化治疗可以在这种羽毛症中有效,因为它通过降低LPO,IL-6,CRP,PCT和增加全身TAC和NO 2 - NO 2,改善了包括沙发,Apache II,SAPS II,Covidgram,GCS的存活评分。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号